12.07.2015 Views

ECR 2013 – Final Programme - myESR.org

ECR 2013 – Final Programme - myESR.org

ECR 2013 – Final Programme - myESR.org

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Scientific Sessions15:03B-0447 Brown adipose tissue influences body fat compositionand hepatic steatosisM.K. Werner, S. Ripkens, M. Schmadl, I. Stef, A. Deckert, C.D. Claussen,C. Würslin, N. Stefan, C. Pfannenberg; Tübingen/DE15:12B-0448 In-phase/opposed-phase MRI and MR spectroscopicmeasurements for the quantification of liver fatcontent in morbidly obese patientsH.H. Bertram 1 , G. Thörmer 2 , N. Garnov 2 , T. Schütz 2 , V. Peter 2 , T. Kahn 2 , H. Busse 2 ;1Munich/DE, 2 Leipzig/DE15:21B-0449 Dynamic contrast enhanced-MRI (DCE-MRI) functionalassessment of vascular events occurring during theintra-hepatic engraftment of pancreatic islets maypredict long-term outcome of islets transplantationA. Palmisano, A. Esposito, G. Ironi, P. Maffi, F. De Cobelli, T. Canu, A. Secchi,A. Del Maschio; Milan/IT14:00–15:30 Room F2BreastSS 602Breast imaging after neoadjuvanttherapy and surgeryModerators: G. Gennaro; Padua/IT, P. Martinez-Miravete; Logroño/ES14:00B-0450 Early response monitoring of neoadjuvantchemotherapy in breast cancer patients usingmagnetic resonance imaging: a systematic reviewM. Lobbes 1 , R. Prevos 1 , M. Smidt 1 , V. Tjan-Heijnen 1 , M. van Goethem 2 ,R.G.H. Beets-Tan 1 , J. Wildberger 1 ; 1 Maastricht/NL, 2 Antwerp/BE14:09B-0451 The role of magnetic resonance imaging in assessingresidual disease and pathologic complete responsein breast cancer patients receiving neoadjuvantchemotherapy: a systematic reviewR. Prevos 1 , M. Smidt 1 , V. Tjan-Heijnen 1 , M. van Goethem 2 , R.-J. Schipper 1 ,R.G.H. Beets-Tan 1 , J. Wildberger 1 , M. Lobbes 1 ; 1 Maastricht/NL, 2 Antwerp/BE14:18B-0452 Radiological evaluation of complete pathologicalresponse after neoadjuvant chemotherapy treatmentof breast carcinomaN.M.A. Abdel Razek, H.A. El Ghazaly, O.Z. Yousef; Cairo/EG14:27B-0453 Breast MRI at 3T: a pilot study estimating the roleof unenhanced MRI (DWI combined with T2 IDEALsequence) vs CE-MRI in the assessment of response toneo-adjuvant chemotherapyF. Vasselli, F. Pediconi, M. Telesca, M. Luciani, V. Casali, E. Miglio, A. Castrignanò,C. Catalano; Rome/IT14:36B-0454 Radiological findings in breast autologous fatinjection: a retrospective review in 12-year follow-upL. Camera, I. Baglio, G. Barbazeni, A. Bianchin, M. Valdo, S. Montemezzi;Verona/IT14:45B-0455 Invasive ductal carcinoma with marked necrosis onneoadjuvant chemotherapy: RECIST or mRECIST in MRIassessment of tumour response?M.M. Nadrljanski, Z.C. Milosevic; Belgrade/RS14:54B-0456 CAD-based assessment of therapy monitoring inneoadjuvant chemotherapy of breast cancerJ.S. Grueneisen 1 , S. Maderwald 1 , T. Heusner 2 , S. Kuemmel 1 , E.A. Hauth 1 ,M. Forsting 1 , T.C. Lauenstein 1 , L. Umutlu 1 ; 1 Essen/DE, 2 Düsseldorf/DE15:03B-0457 Breast MRI for assessment of primary systemicchemotherapy (PSC): computer assisted diagnosis(CAD) predicts degree of tissue response and residualtumour massP.A.T. Baltzer 1 , M. Dietzel 2 , W.A. Kaiser 3 ; 1 Vienna/AT, 2 Erlangen/DE, 3 Jena/DE15:12B-0458 Evaluation of residual breast tissue post-mastectomyusing breast MRIV. Tsehmaister Abitbol, A. Rundstein, A. Shalmon, E. Konen, M. Sklair-Levy;Tel Hashomer/IL15:21B-0459 Breast cancer recurrence in DIEP flap reconstructedbreasts: a 12-year retrospective studyJ.A. Farras Roca, A. Luciani, R. Bosc, E. Meyblum, P. Beaussart, F. Pigneur,Y. Belkacemi, A. Rahmouni, T.-H. Dao; Créteil/FR14:00–15:30 Room G/HCardiacSS 603bCardiomyopathy and fibrosisModerators: P. Donato; Coimbra/PT, R. Maksimović; Belgrade/RS14:00B-0460 Potential value of fibrosis quantification in dilatedcardiomyopathyA. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin;Marseille/FR14:09B-0461 Potential value of fibrosis quantification inhypertrophic cardiomyopathyA. Jacquier, A. Kallifatidis, B. Maurel, A. Flavian, J. Gaubert, J. Bartoli, G. Moulin;Marseille/FR14:18B-0462 Extent of myocardial scar detected by late Gadoliniumenhancement-cardiac magnetic resonance (LGE-CMR)as a predictor of major adverse cardiac events (MACE)in HCM patientsS. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri,R. Lugli; Modena/IT14:27B-0463 Myocardial scar extension detected by late Gadoliniumenhancement-cardiovascular magnetic resonance(LGE-CMR) for arrhythmic risk stratification of HCMpatientsS. Bertugno, G. Ligabue, F. Fiocchi, L. Nocetti, S. Vasaturo, V. Morini, A. Barbieri ,R. Lugli, P. Torricelli; Modena/IT14:36B-0464 Prognostic value of RV remodelling in pulmonaryhypertension: cardiac magnetic resonance studyN. Galea, M. Francone, I. Carbone, I. Iacucci, P. David, C. Vizza, C. Catalano;Rome/IT14:45B-0465 Evaluation of Brugada syndrome by cardiac magneticresonanceL. Salvatori 1 , C. Tessa 1 , i. Del Meglio 1 , S. Diciotti 2 , C. Vignali 1 , G. Casolo 1 ;1Lido di Camaiore/IT, 2 Firenze/ITB-0447 – B-0465Friday237

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!